In the same study, galectin-1 deficient glioma cells were injected into NGS (T, B, and NK cells deficient) or C57BL/6 immunocompetent mice treated with anti-asialo GM1, which depletes NK cells. Here, LGALS1 is linked to central nervous system cancer.